WENDALL WIERENGA - 21 Aug 2023 Form 4 Insider Report for CYTOKINETICS INC (CYTK)

Role
Director
Signature
/s/ John Faurescu, attorney-in-fact for Dr. Wierenga
Issuer symbol
CYTK
Transactions as of
21 Aug 2023
Net transactions value
-$152,306
Form type
4
Filing time
21 Aug 2023, 17:01:27 UTC
Previous filing
05 Jul 2023
Next filing
03 Oct 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYTK Common Stock Options Exercise $40,454 +6,020 +33% $6.72* 24,225 21 Aug 2023 Direct
transaction CYTK Common Stock Sale $192,760 -6,020 -25% $32.02 18,205 21 Aug 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYTK Non-Qualified Stock Option (Right to Buy) Options Exercise $0 -6,020 -100% $0.000000* 0 21 Aug 2023 Common Stock 6,020 $6.72 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).